|Drug class||Thyroid stimulating hormone|
|Main uses||Thyroid cancer|
|Side effects||Nausea, headache|
|US NLM||Thyrotropin alfa|
Thyrotropin alfa, sold under the brand name Thyrogen is a medicine used to find remaining thyroid tissue after surgery. Specifically it is used in thyroid cancer in addition to thyroglobulin testing. It is given by injection into a muscle.
Common side effects include nausea and headache. Other side effects may include high thyroid in those who still have functional thyroid tissue, stroke, and increased thyroid tumor size. It is a manufactured form of thyroid stimulating hormone.
Thyrotropin alfa was approved for medical use in the United States in 1998 and Europe in 2000. In the United States it costs about 3,700 USD for a course of treatment. In the United Kingdom this amount costs the NHS about £580.
- "Thyrotropin Alfa Monograph for Professionals". Drugs.com. Retrieved 4 October 2021.
- BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 813. ISBN 978-0-85711-369-6.CS1 maint: date format (link)
- "Thyrogen". Retrieved 5 October 2021.
- "Thyrogen Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 5 October 2021.